You are on page 1of 2

Eur Child Adolesc Psychiatry

DOI 10.1007/s00787-015-0789-y

LETTER TO THE EDITOR

Disruptive mood dysregulation disorder in ICD‑11: a new


disorder or ODD with a specifier for chronic irritability?
K. C. Runions1 · R. M. Stewart2 · J. Moore2 · Y. Martinez Ladino2 · P. Rao2 ·
F. D. Zepf2,3 

Received: 21 September 2015 / Accepted: 22 October 2015


© Springer-Verlag Berlin Heidelberg 2015

To the Editor, important aspect in the light of the ongoing discussion on


DMDD and ODD. ODD as a diagnostic category has been
We read the article by Mulraney et al. entitled “Comor-
around for many years, but DMDD as a diagnosis is new.
bidity and correlates of disruptive mood dysregulation
However, this does not mean that ODD is either correct or
disorder in 6–8‐year‐old children with ADHD” [1] with
ideal as a diagnostic category, and that it does not need any
great interest. In the study covered in this particular arti-
further revision.
cle, the authors aimed to explore the impact of the new
Indeed, there may yet be unintentional benefits of the
DSM-V diagnosis disruptive mood dysregulation disorder
controversy over DMDD. There is reason to believe the
(DMDD) in children aged 6–8 years with attention-deficit/
current conceptualisation of ODD conflates two commonly
hyperactivity disorder (ADHD), and with a focus on related
co-occurring but distinct phenotypes, irritability and non-
comorbid psychiatric disorders and how DMDD can affect
compliance/oppositional behaviours. Studied as distinct
functioning in daily life. We would like to congratulate the
phenomena, these constructs, respectively, show prospec-
authors on their very important paper.
tive associations with depressive/anxiety problems, and
As stated by the authors, there was a significant diag-
with conduct disorder and ADHD [3–5]. We believe that
nostic overlap of DMDD with oppositional defiant disor-
these findings suggest that both the disorders, DMDD and
der (ODD); and using a proxy DMDD diagnosis contain-
ODD, require an equal amount of scrutiny as diagnostic
ing items from the ODD module of the DISC-IV likely
categories as regards their validity.
impacted such comorbidity patterns. Mulraney et al. [1]
Another relevant related area is the issue of hierarchy in
suggest that the DSM-5 developers might instead have pro-
diagnosis. As the authors have pointed out, DSM-5 man-
posed a diagnostic specifier regarding chronic irritability to
dates a preferential diagnosis of DMDD over ODD, when
the ODD diagnosis, a proposal also recently forwarded for
features of both are deemed to be present. This could,
the ICD-11 [2].
potentially, be construed as meaning that DMDD is a more
While we agree with Mulraney and colleagues [1] and
severe form of ODD. But there are no empirical data, to
acknowledge that their results are of clinical importance,
date, to suggest that this is the case. Further research is
we would like to highlight one further and in our view
therefore needed to clarify constructs that constitute valid
individual diagnostic categories as well as potential over-
* F. D. Zepf lap between categories. At this stage it is not possible to
florian.zepf@uwa.edu.au determine in advance which of the different views on this
1 important clinical topic is correct.
Telethon Kids Institute, Perth, Australia
2
As reflected in the US National Institute of Men-
Department of Child and Adolescent Psychiatry,
tal Health Research Domain Criteria Initiative, a close
The University of Western Australia, 35 Stirling Highway
(M561), Crawley, Perth, WA 6840, Australia examination of particular constructs in mental illness may
3 fruitfully inform better taxonomies and diagnoses [6]. We
Specialised Child and Adolescent Mental Health Services
(CAMHS), Department of Health in Western Australia, believe the controversy over DMDD, and in particular its
Perth, WA, Australia phenotypic overlap with ODD, may be an impetus for a

13
Eur Child Adolesc Psychiatry

close examination of the constructs of angry and irritable Foundation for Medical Research (Raine Visiting Professorship), and
mood as distinct from argumentative and defiant behav- editorial fees from Co-Action Publishing (Sweden). The other authors
have nothing to report or to disclose.
iours and vindictiveness. Research examining the distinct
developmental trajectories of these symptom domains, and
their sensitivity to genetics, epigenetic markers, biomark-
References
ers, and social correlates, may provide a clearer picture
of clinical and behavioral phenotypes as well as possible 1. Mulraney M, Schilpzand EJ, Hazell P, Nicholson JM, Anderson
related subtypes, the underlying mechanisms, aetiology V, Efron D, Silk TJ, Scibrras E (2015) Comborbidity and cor-
and, most importantly, treatment avenues [7]. relates of disruptive mood dysregulation disorder in 6–8-year-
old children with ADHD. Eur Child Adolesc Psychiatry.
Acknowledgements  The research leading to these results is funded doi:10.1007/s00787-015-0738-9
by the European Union’s Seventh Framework Programme (FP7/2007– 2. Lochman JE, Evans SC, Burke JD et al (2015) An empirically
2013) under Grant Agreement No 602407. The funding sources had based alternative to DSM-5’s disruptive mood dysregulation dis-
no role in the writing of the manuscript or the decision to submit it for order for ICD-11. World Psychiatry 14(1):30–33. doi:10.1002/
publication. There was no payment received by any of the authors to wps.20176
write this article by a pharmaceutical company or other agency. The 3. Stringaris A, Baroni A, Haimm C et al (2010) Pediatric bipo-
corresponding author, FDZ, had final responsibility for the decision lar disorder versus severe mood dysregulation: risk for manic
to submit the publication, and all co-authors agreed with this and the episodes on follow-up. J Am Acad Child Adolesc Psychiatry
final version of the manuscript. 49:397–405
4. Okado Y, Bierman KL (2015) Differential risk for late adolescent
Complaince with ethical standards  conduct problems and mood dysregulation among children with
early externalizing behavior problems. J Abnorm Child Psychol
Conflict of interest  FDZ was the recipient of an unrestricted award 43:735–747
donated by the American Psychiatric Association, the American Psy- 5. Rowe R, Costello EJ, Angold A, Copeland WE, Maughan B
chiatric Institute for Research and Education, and AstraZeneca (Young (2010) Developmental pathways in oppositional defiant disorder
Minds in Psychiatry Award). He has also received research support and conduct disorder. J Abnormal Psychol 119(4):726–738
from the German Federal Ministry for Economics and Technology, the 6. Insel TR (2014) The NIMH Research Domain Criteria (RDoC)
European Union, the German Society for Social Pediatrics and Adoles- Project: precision medicine for psychiatry. Am J Psychiatry
cent Medicine, the Paul and Ursula Klein Foundation, the Dr. August 171(4):396–397. doi:10.1176/appi.ajp.2014.14020138
Scheidel Foundation, the IZKF Fund of the University Hospital of 7. Rao P, Moore JK, Stewart RM, Hood S, Runions K, Zepf FD
RWTH Aachen University, and a travel stipend donated by the Glaxo- (2015) Diagnostic inexactitude – Reframing and relabelling Dis-
SmithKline Foundation. He is the recipient of an unrestricted educa- ruptive Mood Dysregulation Disorder for ICD-11 does not solve
tional grant, travel support and speaker honoraria by Shire Pharmaceu- the problem. Med Hypotheses. doi:10.1016/j.mehy.2015.10.008
ticals, Germany. In addition, he has received support from the Raine

13

You might also like